All Stories

  1. CLEC12B Decreases Melanoma Proliferation by Repressing Signal Transducer and Activator of Transcription 3
  2. Dual Covalent Inhibition of PKM and IMPDH Targets Metabolism in Cutaneous Metastatic Melanoma
  3. Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
  4. Germline variants in exonic regions have limited impact on immune checkpoint blockade clinical outcomes in advanced melanoma
  5. Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease
  6. FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells
  7. ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
  8. Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies
  9. 442 CLEC12B a new gene implicated in melanoma
  10. Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo
  11. Efficacy and safety data for checkpoint inhibitors in advanced melanoma under real-life conditions: A monocentric study conducted in Nice from 2010 to 2016
  12. Uncovering and deciphering the pro-invasive role of HACE1 in melanoma cells
  13. Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype
  14. Focus on cutaneous and uveal melanoma specificities
  15. Pharmacological modulation of LMNA SRSF1-dependent splicing abrogates diet-induced obesity in mice
  16. Let-7i-5p represses brite adipocyte function in mice and humans
  17. White-to-brite conversion in human adipocytes promotes metabolic reprogramming towards fatty acid anabolic and catabolic pathways
  18. Visfatin expression analysis in association with recruitment and activation of human and rodent brown and brite adipocytes
  19. The K + channel TASK1 modulates β-adrenergic response in brown adipose tissue through the mineralocorticoid receptor pathway
  20. Oxytocin Reverses Osteoporosis in a Sex-Dependent Manner
  21. The ω6-fatty acid, arachidonic acid, regulates the conversion of white to brite adipocyte through a prostaglandin/calcium mediated pathway
  22. Oxytocin Reverses Ovariectomy-Induced Osteopenia and Body Fat Gain
  23. Antagonistic functions of LMNA isoforms in energy expenditure and lifespan
  24. Chondrogenic potential of stem cells derived from adipose tissue: A powerful pharmacological tool
  25. In vitro brown and “brite”/“beige” adipogenesis: Human cellular models and molecular aspects
  26. Monocytes differentiation upon treatment with a peptide corresponding to the C-terminus of activated T cell-expressed Tirc7 protein
  27. Differentiation of human adipose-derived stem cells into “brite” (brown-in-white) adipocytes
  28. Specific Expression of BMP2/4 Ortholog in Biomineralizing Tissues of Corals and Action on Mouse BMP Receptor
  29. Cloning and Use of a Coral 36B4 Gene to Study the Differential Expression of Coral Genes Between Light and Dark Conditions
  30. Poly(adp-ribose) Polymerase-1 Regulates Tracp Gene Promoter Activity During RANKL-Induced Osteoclastogenesis
  31. Differential Binding of Poly(ADP-Ribose) Polymerase-1 and JunD/Fra2 Accounts for RANKL-Induced Tcirg1 Gene Expression During Osteoclastogenesis
  32. RANKL Treatment Releases the Negative Regulation of the Poly(ADP-Ribose) Polymerase-1 on Tcirg1 Gene Expression During Osteoclastogenesis
  33. RANKL negatively regulates the binding of a 125 KDa transcriptional repressor within the mouse Tcirg1 gene promoter during osteoclastogenesis